Julia Rotow
Medical Oncologist, Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute / Instructor in Medicine at Harvard Medical School
Biography
Harvard Medical School
Dr. Rotow received her M.D. from the UCLA David Geffen School of Medicine. She completed her residency training in Internal Medicine at the Massachusetts General Hospital and her fellowship training in Hematology/Oncology at the University of California, San Francisco. Her research interests include the development of targeted therapies and immunotherapies for the treatment of oncogene-driven lung cancer.
Clinical Interests
- Thoracic oncology
Experience
Medical Oncologist, Lowe Center for Thoracic Oncology
Dana-Farber Cancer InstituteClinical Fellow, Oncology
University of California, San FranciscoMedical Resident
Massachusetts General HospitalPredoctoral Fellow
HHMI-NIH Research Scholars
Education
David Geffen School of Medicine at UCLA
Harvard University
Bachelor of Arts (B.A.), Biochemical Sciences
Videos
Dr. Rotow on Updated ALEX Trial Results in ALK+ NSCLC
Dr. Rotow on Results of a Phase 1/2 Trial With Osimertinib/Gefitinib in EGFR-Mutant NSCLC
Dr. Rotow on the Implications of Next-Generation ALK Inhibitors in NSCLC
Dr. Julia Rotow | Dana-Farber Cancer Institute
Dr. Rotow on Brigatinib Safety Profile in ALK+ NSCLC
Dr. Rotow on Remaining Questions With Brigatinib in ALK+ NSCLC
Dr. Rotow on First-Line Brigatinib Versus Crizotinib in ALK+ NSCLC
Read about executive education
Other experts
Popular Courses
Looking for an expert?
Contact us and we'll find the best option for you.